Search This Blog

Thursday, April 23, 2026

Power vacuum in Tehran emboldens hardliners

 As debate over a ceasefire and renewed talks with the United States intensifies, the absence of a clear supreme arbiter in Tehran appears to be giving Iran’s hardliners more room to shape the narrative and to hinder any eventual agreement.

Under former Supreme Leader Ali Khamenei, ultraconservative factions were often allowed to rage in public, attack moderates and mobilize supporters in the streets. But when necessary, he could impose discipline.

Even on the 2015 nuclear deal, which he later criticized publicly, the system moved quickly once it was understood he had given at least tacit approval.

Then-speaker Ali Larijani famously pushed the JCPOA through parliament in a matter of minutes, effectively silencing opposition by invoking the Supreme Leader’s authority.

Today, who truly leads Iran—whether one man or a shifting collective—is anyone’s guess. What is clearer is that the political vacuum appears to be rewarding the loudest and most uncompromising voices.

Iranian hardliners’ arguments for continuing the war with the United States have come to dominate state television, media reports and billboards across major squares in Tehran.

Many frame negotiations as a betrayal of “red lines,” accusing “accomplices of America and Israel,” “liberals” and those intimidated by Washington of undermining the country.

Those so-called red lines are often justified through selective interpretations of new leader Mojtaba Khamenei’s April 9 message, former Supreme Leader Ali Khamenei’s past speeches rejecting negotiations and claims by individual hardliners citing unnamed “reliable sources.”

One prominent example is ultraconservative MP Amir Hossein Sabeti of the Paydari Party, who has repeatedly warned that negotiators may be crossing the Supreme Leader’s red lines.

In a post on X, he claimed to have “the most definite information” that negotiating with the United States on the nuclear issue was prohibited and demanded that Speaker Mohammad Bagher Qalibaf and Foreign Minister Abbas Araghchi publicly deny reports of talks on suspending enrichment or diluting uranium.

He implied consequences if they did not.

State television has amplified such voices while giving nightly exposure to rallies calling for the war to continue until “final victory.”

The constant need to fill airtime has also elevated more extreme or theatrical voices, including members of the public eager for their moment on air.

Meanwhile, moderate voices arguing for negotiations appear to have lost even the limited channels they once had to plead their case to the country’s highest authority.

Iranian academic Sadeq Zibakalam, speaking to the reform-leaning Fararu website, questioned why some factions remain so insistent on continuing the war despite the economic devastation already inflicted.

“Do these gentlemen know what forty days of war has done to our economy, how many production units have run into trouble, and how many have laid off their workers?” he asked.

He said it was striking that hardline revolutionaries inside Iran, opposition groups seeking regime change and Israeli officials all appeared to share an interest in prolonging the conflict.

Views such as Zibakalam’s were once represented within inner circles of power by figures like former president Hassan Rouhani, who had direct access to Ali Khamenei, even if he rarely got his way.

President Masoud Pezeshkian has no such standing as the veteran Rouhani. And whatever limited influence he might have enjoyed under Khamenei Sr. appears to have diminished further under Khamenei Jr., who—even if in good health—remains almost certainly beyond the reach of civilian leaders.

In the absence of a clear authority to impose discipline or bless compromise, political competition in Tehran increasingly appears to favor the fiercest factions.

https://www.iranintl.com/en/202604234667

DOJ reclassifies marijuana products: What it means for healthcare

 The Justice Department and Drug Enforcement Administration have placed FDA-approved products containing marijuana and state-licensed medical marijuana products in Schedule III of the Controlled Substances Act. 

The order takes effect immediately and also initiates an expedited administrative hearing process to evaluate broader rescheduling of marijuana from Schedule I to Schedule III, indicating accepted medical use. A hearing is set for June 29, according to an April 23 news release from the Justice Department. 

Marijuana was previously classified as a Schedule I substance, a category reserved for drugs such as heroin, ecstasy and LSD. In August 2023, HHS recommended the DEA reclassify the drug to Schedule III after determining it poses less risk than other Schedule I substances. The FDA reinforced that position in January 2024, citing preclinical, clinical and epidemiologic data. 

Acting Attorney General Todd Blanche authorized the action under his authority to reschedule drugs, citing the need to align with state medical marijuana programs while maintaining federal controls. The rescheduling allows for research on the safety and efficacy of the substance, he said in the release.

The DEA is also withdrawing a prior notice of hearing published Aug. 29, 2024, tied to a proposed rulemaking first issued May 21, 2024, to accelerate the administrative process. The agency said the updated process will include firm deadlines to support a more timely resolution. 

The move follows President Donald Trump’s executive order in December directing the attorney general to start the rulemaking process to reschedule marijuana to Schedule III. Mr. Trump also recently signed an order to boost research on psychedelics, including ibogaine and psilocybin

Twenty-four states, two U.S. territories and the District of Columbia have legalized small amounts of marijuana for adult recreational use.

https://www.beckershospitalreview.com/behavioral-health-government-policies/justice-department-reclassifies-marijuana-products-what-it-means-for-healthcare/

GPS darts can now track fleeing cars in NY: Police

 A new technology currently being piloted allows officers to track high-risk pursuits.

The StarChase system, now implemented by the Suffolk County’s DWI enforcement team, works by launching a GPS‑activated dart onto a fleeing vehicle, allowing officers to monitor its real‑time location, speed and direction, according to officials.

The Suffolk County Sheriff’s Office is the first law enforcement agency in the county to pilot the technology.

The system was implemented March 24 and first used during a DWI arrest in East Patchogue on April 1, when a suspect refused to yield. The driver was later charged with aggravated DWI, according to Suffolk County police.

Officials said the dart is secured with strong adhesive, making it unlikely a suspect could remove it.

The technology costs about $9,000 per vehicle, including equipment and installation, and was funded through the agency’s operating budget, according to police.

“We have seen dozens of people try to evade arrest, causing dangerous situations for themselves, our officers and the community at large,” Suffolk County Sheriff Errol D. Toulon Jr. said in a statement. “With our DWI team equipped with the StarChase GPS technology, it will help them apprehend subjects during high‑risk events by safely giving our officers access to their real‑time location, speed and direction.”

The technology has proven over 85% effectiveness in cases involving fleeing vehicles, stolen cars, DUIs, human trafficking, narcotics trafficking and other offenses, according to Suffolk County police.

https://pix11.com/news/gps-darts-can-now-track-fleeing-cars-in-ny-police/

Medpace Flags Rising Cancellations, Near-Term Growth Uncertain

 CEO August Troendle highlighted that the current quarter saw cancellations rise again, with backlog cancellations reaching their highest point in over a year.

Most of the cancellations in the quarter were oncology and cardiovascular.

In an investor call, the CEO said that the cancellations remain elevated across both backlog and pre-backlog, creating near-term revenue pressure.

Sequential growth is expected to be flat, as reflected in the first quarter versus the rest of the year, though year-over-year growth should still hold.

Visibility beyond the next two quarters is limited, and management is not yet in a position to assess 2027.

Overall, the near-term growth trajectory — both now and over the next six months — remains uncertain.

https://www.benzinga.com/markets/earnings/26/04/52012553/medpace-flags-rising-cancellations-near-term-growth-uncertain

Male Prisoners Are Abusing Incarcerated Women in Massachusetts

 Last month, the U.S. Department of Justice issued a press release announcing an investigation into gender self-identification policies in women’s prisons. The decision comes against the backdrop of mounting allegations of “rape, voyeurism, and a pervasive climate of sexual intimidation” in states where male inmates are housed according to their self-declared “gender identity.” Under the authority of the Civil Rights of Institutionalized Persons Act (CRIPA), the Justice Department will determine whether facilities in California and Maine have exposed incarcerated women to “unconstitutional risks of harm from male inmates.”

Massachusetts should be the next jurisdiction on the list. Just west of Boston, the state’s MCI–Framingham facility houses at least 11 trans-identified men, including serial rapists, wife-murderers, and child molesters, whose presence imposes degrading and dangerous conditions on female inmates. (MCI–Framingham did not return a request for comment for this article.)

Charles Horton, a level-three sex offender, was sentenced in 2000 to one year of house arrest for raping a minor. In 2019, he was convicted of repeatedly kidnapping and sexually assaulting a 14-year-old at gunpoint. He is now serving a 25- to 35-year sentence at MCI–Framingham as “Charlise.”

Wayne “Veronica” Raymond, classified as a “sexually dangerous person,” spent 24 years at the Massachusetts Treatment Center for sex offenders and was denied parole six times for failing to demonstrate rehabilitative progress. Records describe a manipulative personality and persistent “deviant fantasies,” noting that he has “only recently begun admitting to [his] sexually abusive behaviors.”

Kenneth Hunt, now “Katheena Soneeya,” was convicted of sexually assaulting and murdering two women, including his own cousin, whom he raped with a broom handle and stabbed more than 40 times. Women incarcerated with Hunt describe him as a “pervert”; multiple inmates have accused him of sexual assault and harassment in statements they provided us.

Female prisoners are forced to share intimate spaces, including communal showers, with these men—only a few of the predatory offenders transferred to MCI–Framingham under the 2018 Criminal Justice Reform Act, which does not require even a diagnosis of gender dysphoria.

Inmates are not the only ones affected. Female correctional officers are required to strip-search male offenders who request female staff—an accommodation granted to all men housed at the facility, according to internal Massachusetts Department of Correction (MADOC) documents.

MADOC has denied exemption requests from officers who have been victimized by sexual assault and with histories of documented PTSD, forcing them to comply or risk their jobs. Danielle Laurenti alleged she was warned that she could be held in contempt of court after refusing a direct order to strip-search a male inmate. In July 2025, she told the Independent Women’s Forum that she endures the searches by pinching the inside of her arm to keep from crying. “These men . . . they enjoy it,” she said. “A lot of them have crimes against women. They get off on being naked in front of us. They know what they’re doing.”

Efforts to reform gender self-identification policies have focused on barring men convicted of sexual offenses from women’s prisons. But prior convictions don’t reliably predict who will pose a threat to female inmates.

James “Jennaya” Bennett-Werra is serving time for crimes ranging from attempted bank robbery to vehicular homicide. Though not sexually motivated, he has accumulated multiple Prison Rape Elimination Act violations at MCI–Framingham. One inmate, granted anonymity because she fears retaliation, alleges that Bennet-Werra assaulted her in November 2025 in the Secure Adjustment Unit. He had previously been placed there after earlier allegations of sexual misconduct.

The only way to ensure the safety of incarcerated women is to maintain the sex-based placement standards that prisons have relied on for decades. But that principle matters only if female prisoners matter. In Massachusetts, state officials have signaled their indifference to conditions at MCI–Framingham, detailed by one of us in The Hill, including Prison Rape Elimination Act (PREA) noncompliance and allegations of cover-ups and retaliation against inmates who report abuse by trans-identified males.

Even institutions established to “provide a . . . voice for women and girls” are now rebuking those who speak up. At an October 2025 public hearing, one of us raised concerns about male inmates at MCI–Framingham before the Massachusetts Commission on the Status of Women. Chairwoman Mary-dith Tuitt promised to “research that,” saying that the commission was unaware that any men had been transferred to the facility.

Five months later, several more women testified before MCSW, warning that female inmates “are literally trapped” with dangerous male prisoners. Tuitt again said that the commission was unaware and would look into it “next year.” She also called their testimony “phobic,” “threatening,” inhumane, and unworthy of the commission’s support. Vice Chair Christine Monska echoed the sentiment, affirming that “transwomen are women and should have equal access to human rights.” Giselle Byrd—appointed to MCSW by Governor Maura Healey and described as its “first Black trans woman”—compared the testimony with “the oppressive South that my grandparents survived.”

Judith Schiavone, who spoke at the hearing in support of single-sex spaces, described the commission’s response as “essentially being told to ‘shut up.’” She later wrote to the executive director requesting an apology.

MCSW has not publicly responded to Schiavone’s letter or addressed the commissioners’ conduct, and did not respond to a request for comment by press time. Video footage—typically posted within days—has not been made available. The commission has repeatedly delayed or withheld recordings of testimony on male inmates at MCI–Framingham: footage from the October 2025 hearing did not appear for several months and, when it was finally released, was not posted to MCSW’s official channel.

While the commission remains cold to the plight of women at MCI–Framingham, it has rallied against a “campaign of hateful anti-trans legislation,” committing to “support the trans community . . . in bringing awareness, stopping the violence intimated against them, and codifying their human rights as undisputed law.”

The Justice Department should bring its investigation to Massachusetts. Those in power clearly have little incentive to self-correct. In a healthy political system, competing parties must produce policies that their constituents value, knowing voters may take their support elsewhere if officials fail to deliver. That system breaks down in a state like Massachusetts, where the monopolistic dominance of single-party leadership undermines accountability.

While state officials focus on other priorities—declaring Massachusetts a sanctuary for “gender-affirming care,” funding legal defense programs for illegal immigrants, and defending “the trans community” against the “fascist” Trump administration—women at MCI–Framingham are being subjected to sexual abuse by men who have exploited a loophole opened by reckless progressive reforms. If the DOJ does not investigate MCI–Framingham for constitutional violations, who will?

Trump: Israel-Lebanon ceasefire extended by 3 weeks

 United States President Donald Trump announced on Thursday that the ceasefire between Israel and Lebanon, which was due to expire on April 26, will be extended by three weeks.

The extension was reached following a meeting in the White House, which was attended by himself, other top US officials, including US Vice President JD Vance and State Secretary Marco Rubio and high-ranking Israeli and Lebanese representatives. "The Meeting went very well! The United States is going to work with Lebanon in order to help it protect itself from Hezbollah," Trump wrote on Truth Social.

"I look forward in the near future to hosting the Prime Minister of Israel, Bibi Netanyahu, and the President of Lebanon, Joseph Aoun," he added.

https://breakingthenews.net/Article/Trump:-Israel-Lebanon-ceasefire-extended-by-3-weeks/66139838

IKS Health to acquire TruBridge for $26.25 per share in cash

 


  • Closing expected in the third quarter of 2026, subject to TruBridge shareholder and regulatory approvals.